Kinetics of immunologic responses after primary MMR vaccination

Vaccine

Volumn 15, Issue 1, 1997, Pages 10-14

  Pabst, Henry F ^a   Spady, Donald W ^a   Carson, Mary M ^a   Stelfox, H Tom ^a   Beeler, Judy A ^b   Krezolek, Margaret P ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

immunologic responses; infants; measles; vaccination

Indexed keywords

GAMMA INTERFERON; MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMORAL IMMUNITY; INFANT; KINETICS; MAJOR CLINICAL STUDY; MEASLES; MUMPS; PRIORITY JOURNAL; VACCINATION;

ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNITY, CELLULAR; INFANT; INTERLEUKINS; KILLER CELLS, NATURAL; KINETICS; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; NEUTRALIZATION TESTS; RUBELLA VACCINE; VACCINES, COMBINED;

EID: 0031017821     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00124-7     Document Type: Article

References (25)

1. 1 McChesney, M.B. and Oldstone, M.B.A. Virus-induced immunosuppression: infections with measles virus and human immunodeficiency virus. Adv. Immun. 1989, 45, 335-347
2. 2 Wainberg, M.A. and Mills, E.L. Mechanisms of virus-induced immune suppression. Can. Med. Assoc. J. 1985, 132, 1261-1267
3. 3 Lamb, G.A. Effect of HPV-80 rubella vaccine on the tuberculin reaction. Am. J. Dis. Child. 1969, 118, 261
4. 4 Berkovich, S., Steiner, P. and Steiner, M. Live rubella virus vaccine in tuberculous children. Am. J. Dis. Child. 1969, 118, 252-257
5. 5 Zweiman, B., Pappagianis, D., Maibach, H. and Hildreth, E.A. Effect of measles immunization on tuberculin hypersensitivity and in vitro lymphocyte reactivity. Int. Arch. Allergy 1971, 40, 834-841
6. 6 Hirsch, R.L., Mokhtarian, F., Griffin, D.E., Brooks, B.R., Hess, J. and Johnson, R.T. Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production. Clin. Immun. Immunopathol. 1981, 21, 341-350
7. 7 Garenne, M., Leroy, O., Beau, J.-P. and Sene, I. Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet 1991, 338, 903-907
8. 8 Lennon, J.L. and Black, F.L. Maternally derived measles immunity in era of vaccine-protected mothers. J. Pediatr. 1986, 108, 671-676
9. 9 Pabst, H.F., Spady, D.W., Marusyk, R.G. et al. Reduced measles immunity in infants in a well-vaccinated population. Pediatr. Infect. Dis. J. 1992, 11, 525-529
10. 10 Carson, M.M., Spady, D.W., Albrecht, P. et al. Measles vaccination of infants in a well-vaccinated population. Pediatr. Infect. Dis. J. 1995, 14, 17-22
11. 11 Stratton, K.R., Howe, C.J. and Johnston, R.B. Adverse Events Associated with Childhood Vaccines. Evidence Bearing on Causality. Vaccine Safety Committee, Division of Health Promotion and Disease Prevention, Institute of Medicine. National Academy Press, Washington, D.C. 1994
12. 12 Chen, R.T., Markowitz, L.E., Albrecht, P. et al. Measles antibody: reevaluation of protective titres. J. Infect. Dis. 1990, 162, 1036-1042
13. 13 Good, R.A., Zak, S.J. Disturbances in gamma globulin synthesis as "experiments of nature". Pediatrics 1956, 18, 109-149
14. 14 Monafo, W.J., Haslam, D.B., Roberts, R.L., Zaki, S.R., Bellini, W.J. and Coffin, C.M. Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J. Pediatr. 1994, 124, 273-276
15. 15 Griffin, D.E. and Ward, B.J. Differential CD4 T cell activation in measles. J. Infect. Dis. 1993, 168, 275-281
16. 16 Ward. B.J. and Griffin, D.E. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin. Immun. Immunopathol. 1993, 67, 171-177
17. 17 Pabst, H.F., Godel, J., Grace, M., Cho, H. and Spady, D.W. Effect of breast-feeding on immune response to BCG vaccination. Lancet 1989, 295-297
18. 18 Albrecht, P. and Herrmann, K. Role of virus strain in conventional and enhanced measles plaque neutralization test. J. Virol. Meth. 1981, 3, 251-260
19. 19 Samb, B., Aaby, P., Whittle, H.C. et al. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr. Infect. Dis. J. 1995, 14, 203-209
20. 20 van Binnendijk, R.S., van der Heijden, R.W.J., van Amerongen, G., UytdeHaag, F.G.C.M. and Osterhaus, A.D.M.E. Viral replication and development of specific immunity in Macaques after infection with different measles virus strains. J. Infect. Dis. 1994, 170, 443-448
21. 21 Griffin, D.E. and Ward, B.J. Differential CD4 T cell activation in measles. J. Infect. Dis. 1993, 168, 275-281
22. 22 Munyer, T.P., Mangi, R.J., Dolan, T. and Kantor, F.S. Depressed lymphocyte function after measles-mumps-rubella vaccination. J. Infect. Dis. 1975, 132, 75-78
23. 23 Midulla, M., Businco, L. and Moschini, L. Some effects of rubella vaccination on immunologic responsiveness. Acta Psediatr. Scand. 1972, 61, 609-611
24. 24 Hall, C.B. and Kantor, F.S. Depression of established delayed hypersensitivity by mumps virus. J. Immun. 1972, 108, 81-85
25. 25 Wyde, P.R., Attibele, N.R. and Kemp, W.L. Infection of leucocytes by measles vaccine viruses Edmonston-Zagreb and Enders-Moraten has different consequences: potential mechanism for increased vaccine efficacy or aberrant activity in field trials. Vaccine 1994, 12, 715-722